Date: 2026-02-19Category: Not ApplicableState: Union GovernmentCountry: Europe
Commission Implementing Regulation (EU) 2026/398 of 18 February 2026 amending Implementing Regulation (EU) No 686/2012 as regards the allocation to Member States, for the purposes of the renewal procedure, of the evaluation of metconazole and quinolin-8-ol
Issued by European Commission
· Directorate-General for Health and Food Safety
**Executive Summary**
Commission Implementing Regulation (EU) 2026/398, dated 18 February 2026, amends Implementing Regulation (EU) No 686/2012, allocating Member States for the evaluation of metconazole and quinolin-8-ol within the renewal procedure. It specifies rapporteur and co-rapporteur Member States for these active substances. The regulation enters into force twenty days after its publication in the Official Journal of the European Union.
**Key Points / Main Content**
* **Amendment to Implementing Regulation (EU) No 686/2012:**
* Part E of the Annex is amended to allocate rapporteur and co-rapporteur Member States for the evaluation of metconazole and quinolin-8-ol.
* **Allocation of Member States:**
* Sweden (SE) is designated as the rapporteur Member State and Belgium (BE) as the co-rapporteur Member State for metconazole.
* The Netherlands (NL) is designated as the rapporteur Member State and Belgium (BE) as the co-rapporteur Member State for quinolin-8-ol.
* **Entry into Force:**
* The Regulation enters into force twenty days following its publication in the Official Journal of the European Union.
**Impact Analysis**
**Rapporteur Member States (Sweden and Netherlands):**
**Impact**
Responsible for evaluating the active substances Metconazole and Quinolin-8-ol, respectively, as part of the renewal procedure.
**Action Required**
Conduct the evaluation and prepare the necessary reports within the framework of the renewal procedure.
**Co-rapporteur Member State (Belgium):**
**Impact**
Supports the rapporteur Member States in the evaluation of the active substances Metconazole and Quinolin-8-ol as part of the renewal procedure.
**Action Required**
Collaborate with the rapporteur Member States (Sweden and Netherlands) to provide support and expertise in the evaluation process.
**Member States (All):**
**Impact**
The regulation is binding and directly applicable in all Member States, affecting the process of active substance evaluation for renewal.
**Action Required**
Ensure compliance with the new allocations and facilitate the evaluation process according to the updated regulation.
Key Entities Referenced
Implementing Regulation (EU) No 686/2012: The regulation being amended regarding the allocation to Member States for the renewal procedure of active substances.
Regulation (EC) No 1107/2009: Regulation concerning the placing of plant protection products on the market.
Metconazole: Active substance whose evaluation is allocated to specific member states.
Quinolin-8-ol: Active substance whose evaluation is allocated to specific member states.
European Union Member States: The countries to which active substance evaluations are allocated.
Official Journal EN
of the European Union L series
2026/398 19.2.2026
COMMISSION IMPLEMENTING REGULATION(EU) 2026/398
of 18 February 2026
amending Implementing Regulation (EU) No 686/2012 as regards the allocation to Member States,
for the purposes of the renewal procedure, of the evaluation of metconazole and quinolin-8-ol
(Text with EEA relevance)
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009
concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC
and 91/414/EEC(1), and in particular Article 19 thereof,
Whereas:
(1) Commission Implementing Regulation (EU) No 686/2012(2) allocates the evaluation of active substances to a
rapporteur Member State and to a co-rapporteur Member State for the purposes of the renewal procedure. The
evaluation of active substances whose approval expires between 31 January 2029 and 1 October 2035 was allocated
to a rapporteur Member State and a co-rapporteur Member State by Commission Implementing Regulation
(EU) 2023/543(3).
(2) Commission Implementing Regulation (EU) 2024/1749(4) renewed the approval of the active substance
metconazole until 31 August 2031 and Commission Implementing Regulation (EU) 2025/1152(5) renewed the
approval of the active substance quinolin-8-ol until 30 June 2032. No allocations of rapporteur Member States and
co-rapporteur Member States have yet taken place for the evaluation of those two active substances. It is therefore
appropriate to proceed with such allocation.
(3) The allocations should ensure a balance between Member States as regards the distribution of the responsibilities and
the work.
(4) Implementing Regulation (EU) No 686/2012 should therefore be amended accordingly.
(5) The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on
Plants, Animals, Food and Feed,
(1) OJ L 309, 24.11.2009, p. 1, ELI: http://data.europa.eu/eli/reg/2009/1107/oj.
(2) Commission Implementing Regulation (EU) No 686/2012 of 26 July 2012 allocating to Member States, for the purposes of the
renewal procedure, the evaluation of the active substances whose approval expires by 31 December 2018 at the latest (OJ L 200,
27.7.2012, p. 5, ELI: http://data.europa.eu/eli/reg_impl/2012/686/oj).
(3) Commission Implementing Regulation (EU) 2023/543 of 9 March 2023 amending Implementing Regulation (EU) No 686/2012 as
regards the allocation to Member States, for the purposes of the renewal procedure, of the evaluation of active substances whose
approval expires between 31 January 2029 and 1 October 2035 (OJ L 73, 10.3.2023, p. 1, ELI: http://data.europa.eu/eli/reg_impl/
2023/543/oj).
(4) Commission Implementing Regulation (EU) 2024/1749 of 24 June 2024 renewing the approval of the active substance metconazole
as a candidate for substitution in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and
amending Commission Implementing Regulation (EU) No 540/2011 (OJ L, 2024/1749, 25.6.2024, ELI: http://data.europa.eu/eli/
reg_impl/2024/1749/oj).
(5) Commission Implementing Regulation (EU) 2025/1152 of 11 June 2025 renewing the approval of the active substance quinolin-8-ol
as a candidate for substitution in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and
amending Commission Implementing Regulations (EU) No 540/2011 and (EU) 2015/408 (OJ L, 2025/1152, 12.6.2025, ELI: http://
data.europa.eu/eli/reg_impl/2025/1152/oj).
ELI: http://data.europa.eu/eli/reg_impl/2026/398/oj 1/2EN
OJ L, 19.2.2026
HAS ADOPTED THIS REGULATION:
Article 1
Part E of the Annex to Implementing Regulation (EU) No 686/2012 is amended as follows:
(1) the following entry is inserted after the entry for ‘Metalaxyl-M’:
Rapporteur Member Co-rapporteur Member
Active substance
State State
‘Metconazole SE BE’
(2) the following entry is inserted after the entry for ‘Pyriproxyfen’:
Rapporteur Member Co-rapporteur Member
Active substance
State State
‘Quinolin-8-ol NL BE’
Article 2
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the
European Union.
This Regulation shall be binding in its entirety and directly applicable in all Member States.
Done at Brussels, 18 February 2026.
For the Commission
The President
Ursula VON DER LEYEN
2/2 ELI: http://data.europa.eu/eli/reg_impl/2026/398/oj